affordable and timely diagnosis of lifestyle-related diseases has become a growing issue in the present world, where life habit changes occur and cause complexity.
The leading global pharmaceutical company Lupin Limited (Lupin) revealed that it had been authorized by the United States Food and Drug Administration (FDA) to provide an abbreviated new drug application
In connection with the International Institute of Health Management with Research International Delhi and the Indian Institute of Technology (IIT) Bombay, UNICEF has developed a digital course that healthcare professionals
Biocon received approval for its complex drug-device combination Liraglutide (6mg/ml solution for injection in a pre-filled pen) from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).
The prioritization of medicines (PRIME) status has been granted to pegozafermin, a drug developed by 89bio for the non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH)
Healis Therapeutics, a company focused on neurotherapeutics, has recently announced its clinical collaboration with General Hospital (MGH) and Harvard Medical School (HMS) affiliates.
According to recent reports from Russian media, India emerged as the largest pharmaceutical supplier to Russia in 2023, replacing the previously dominant Western companies.
Indian pharmaceutical companies are currently focused on developing flagship products or mother brands. These are designed to incorporate various new combinations and ensure robust revenue growth and therapy leadership.
The National Institute of Mental Health and Neuro Sciences (NIMHANS) recently displayed Electroconvulsive, which is considered to be one of the earliest medical treatments that has shown reasonable effectiveness in treating severe
Dr. Kuldeep Sachdeva, President and Chief Medical Officer (CMO) of Molbio Diagnostics, has emphasized implementing national essential diagnostic guidelines in India to revolutionize healthcare delivery.
, CDSCO.jpg)
